{"database": "openregs", "table": "federal_register", "rows": [["E9-30222", "Implantation or Injectable Dosage Form New Animal Drugs; Polysulfated Glycosaminoglycan", "Rule", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Luitpold Pharmaceuticals, Inc. The supplemental NADA provides for additional vial sizes for an injectable solution of polysulfated glycosaminoglycan.", "2009-12-21", 2009, 12, "https://www.federalregister.gov/documents/2009/12/21/E9-30222/implantation-or-injectable-dosage-form-new-animal-drugs-polysulfated-glycosaminoglycan", "https://www.govinfo.gov/content/pkg/FR-2009-12-21/pdf/E9-30222.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Luitpold Pharmaceuticals, Inc. The supplemental NADA provides for additional vial sizes for...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["E9-30222"], "units": {}, "query_ms": 0.4227980971336365, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}